Literature DB >> 2365529

In vitro autoradiographic localization of binding to angiotensin receptors in the rat heart.

A M Allen1, H Yamada, F A Mendelsohn.   

Abstract

The distribution of binding to angiotensin II receptors in the rat heart was determined by quantitative in vitro autoradiography employing 125I-[Sar1, Ile8] angiotensin II as the radioligand. Low density binding occurs in the myocardium of both the atriums and ventricles and in the media of the aorta, pulmonary arteries and superior caval vein. Dense punctate binding is found over parasympathetic nerve bundles and some cells of the intracardiac ganglions. Binding is very low in nerves which do not stain for acetylcholinesterase. A moderate to high density of binding sites occurs throughout the conduction system, including the sinus node (low), the atrioventricular node (high) and the atrioventricular bundle (moderate). An extremely high density of binding is observed over the remnant of the arterial duct. These findings demonstrate many sites at which angiotensin II could exert its cardiac actions, including anatomical evidence supporting an action on cardiac myocytes, terminals of the vagal nerves, parasympathetic ganglion cells, and the conduction system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365529     DOI: 10.1016/0167-5273(90)90005-p

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block.

Authors:  L Hein; M E Stevens; G S Barsh; R E Pratt; B K Kobilka; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

Authors:  Peiyong Zhai; Mitsutaka Yamamoto; Jonathan Galeotti; Jing Liu; Malthi Masurekar; Jill Thaisz; Keiichi Irie; Eric Holle; Xianzhong Yu; Sabina Kupershmidt; Dan M Roden; Thomas Wagner; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

3.  Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice.

Authors:  T Matsusaka; H Katori; T Inagami; A Fogo; I Ichikawa
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

Review 4.  Subtype 2 and atypical angiotensin receptors in the human heart.

Authors:  V Regitz-Zagrosek; M Neuss; C Warnecke; J Holzmeister; A G Hildebrandt; E Fleck
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

5.  Type-1 angiotensin receptors are expressed and transported in motor and sensory axons of rat sciatic nerves.

Authors:  Hui Tang; Jaroslav Pavel; Juan M Saavedra; Stephen Brimijoin
Journal:  Neuropeptides       Date:  2009-02-23       Impact factor: 3.286

Review 6.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

7.  Expression of AT2 receptors in the developing rat fetus.

Authors:  E F Grady; L A Sechi; C A Griffin; M Schambelan; J E Kalinyak
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.

Authors:  Rhiannon Coulson; Seng H Liew; Angela A Connelly; Nicholas S Yee; Siddhartha Deb; Beena Kumar; Ana C Vargas; Sandra A O'Toole; Adam C Parslow; Ashleigh Poh; Tracy Putoczki; Riley J Morrow; Mariah Alorro; Kyren A Lazarus; Evie F W Yeap; Kelly L Walton; Craig A Harrison; Natalie J Hannan; Amee J George; Colin D Clyne; Matthias Ernst; Andrew M Allen; Ashwini L Chand
Journal:  Oncotarget       Date:  2017-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.